InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Mcgovern Mark e, Director. Officer active across 1 company, notably Esperion Therapeutics, Inc.. In total, 1 filings have been published. History available since 27 May 2021. The latest transaction was filed on 27 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mcgovern Mark e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
12,376 shares0Common StockSEC:0001628280-21-011360:0
1 of 1 declaration
About Mcgovern Mark e
Mark E. McGovern serves as a Director at Esperion Therapeutics, Inc. In this role, he contributes to the company's strategy and governance. His expertise in the biopharmaceutical sector is an asset to the board.
